Andres Miguez
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Clusterin deficiency is associated with a lack of response to teriflunomide in multiple sclerosis.
Journal: Clinical and translational medicine
Published: January 11, 2024
Soluble mutant huntingtin drives early human pathogenesis in Huntington's disease.
Journal: Cellular and molecular life sciences : CMLS
Published: November 05, 2022
Inflammation in multiple sclerosis induces a specific reactive astrocyte state driving non-cell-autonomous neuronal damage.
Journal: Clinical and translational medicine
Published: February 01, 2022
Reduced Fractalkine Levels Lead to Striatal Synaptic Plasticity Deficits in Huntington's Disease.
Journal: Frontiers in cellular neuroscience
Published: March 29, 2020
Human Pluripotent Stem Cell-Derived Neurons Are Functionally Mature In Vitro and Integrate into the Mouse Striatum Following Transplantation.
Journal: Molecular neurobiology
Published: July 13, 2019
CD200 is up-regulated in R6/1 transgenic mouse model of Huntington's disease.
Journal: PloS one
Published: July 08, 2019
Early Downregulation of p75NTR by Genetic and Pharmacological Approaches Delays the Onset of Motor Deficits and Striatal Dysfunction in Huntington's Disease Mice.
Journal: Molecular neurobiology
Published: March 13, 2018
Helios expression coordinates the development of a subset of striatopallidal medium spiny neurons.
Journal: Development (Cambridge, England)
Published: April 05, 2016
Decreased glycogen synthase kinase-3 levels and activity contribute to Huntington's disease.
Journal: Human molecular genetics
Published: May 28, 2015
Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation.
Journal: Human molecular genetics
Published: February 27, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026